Your browser doesn't support javascript.
loading
Chk1 Inhibition Ameliorates Alzheimer's Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling.
Hu, Wenting; Wang, Zhuoqun; Zhang, Huiliang; Mahaman, Yacoubou Abdoul Razak; Huang, Fang; Meng, Dongli; Zhou, Ying; Wang, Shiyi; Jiang, Nan; Xiong, Jing; Westermarck, Jukka; Lu, Youming; Wang, Jianzhi; Wang, Xiaochuan; Shentu, Yangping; Liu, Rong.
Afiliação
  • Hu W; Department of Pathophysiology, Key Laboratory of Ministry of Education for Neurological Disorders, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Wang Z; Department of Pathophysiology, Key Laboratory of Ministry of Education for Neurological Disorders, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhang H; Department of Pathophysiology, Key Laboratory of Ministry of Education for Neurological Disorders, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Mahaman YAR; Department of Pathophysiology, Key Laboratory of Ministry of Education for Neurological Disorders, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Huang F; Cognitive Impairment Ward of Neurology Department, The Third Affiliated Hospital of Shenzhen University, Shenzhen, China.
  • Meng D; Department of Pathophysiology, Key Laboratory of Ministry of Education for Neurological Disorders, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhou Y; Department of Pathophysiology, Key Laboratory of Ministry of Education for Neurological Disorders, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Wang S; Department of Nephrology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Jiang N; Wenzhou Medical University, Wenzhou, China.
  • Xiong J; Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Westermarck J; Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Lu Y; Turku Centre for Biotechnology, University of Turku and Abo Akademi University, Turku, Finland.
  • Wang J; Institute of Biomedicine, University of Turku, Turku, Finland.
  • Wang X; Collaborative Innovation Center for Brain Science, The Institute of Brain Research, Huazhong University of Science and Technology, Wuhan, China.
  • Shentu Y; Department of Pathophysiology, Key Laboratory of Ministry of Education for Neurological Disorders, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Liu R; Department of Pathophysiology, Key Laboratory of Ministry of Education for Neurological Disorders, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. wxch@mails.tjmu.edu.cn.
Neurotherapeutics ; 19(2): 570-591, 2022 03.
Article em En | MEDLINE | ID: mdl-35286657
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Etiology_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Etiology_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article